PHP

Parkman Healthcare Partners Portfolio holdings

AUM $864M
1-Year Return 33.7%
This Quarter Return
+40.67%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$415M
AUM Growth
+$24.6M
Cap. Flow
-$37.8M
Cap. Flow %
-9.11%
Top 10 Hldgs %
39.8%
Holding
104
New
20
Increased
36
Reduced
26
Closed
21

Top Buys

1
UTHR icon
United Therapeutics
UTHR
$12.5M
2
AMGN icon
Amgen
AMGN
$11.2M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
$4.08M
4
DHR icon
Danaher
DHR
$3.89M
5
EDAP
EDAP TMS
EDAP
$3.73M

Top Sells

1
VCEL icon
Vericel Corp
VCEL
$16.2M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$9.87M
3
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$9.41M
4
GNMK
GenMark Diagnostics, Inc
GNMK
$9.02M
5
SDGR icon
Schrodinger
SDGR
$8.82M

Sector Composition

1 Healthcare 95.8%
2 Technology 1.14%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KRMD icon
76
KORU Medical Systems
KRMD
$190M
$921K 0.21%
261,722
-439,537
-63% -$1.55M
RAPT icon
77
RAPT Therapeutics
RAPT
$197M
$896K 0.21%
5,046
+1,899
+60% +$337K
CSLT
78
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$756K 0.18%
+500,393
New +$756K
AUPH icon
79
Aurinia Pharmaceuticals
AUPH
$1.62B
$644K 0.15%
49,581
-39,922
-45% -$519K
BFLY icon
80
Butterfly Network
BFLY
$375M
$510K 0.12%
+30,315
New +$510K
APEN
81
DELISTED
Apollo Endosurgery, Inc.
APEN
$413K 0.1%
+75,000
New +$413K
KPRX icon
82
Kiora Pharmaceuticals
KPRX
$9.51M
$375K 0.09%
+209
New +$375K
SDC
83
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
– –
-175,691
Closed -$2.1M
CNCE
84
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-50,290
Closed -$636K
PHAS
85
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
– –
-110,547
Closed -$371K
GWPH
86
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-81,573
Closed -$9.41M
GNMK
87
DELISTED
GenMark Diagnostics, Inc
GNMK
– –
-617,722
Closed -$9.02M
EIDX
88
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
– –
-21,609
Closed -$2.84M
ABBV icon
89
AbbVie
ABBV
$375B
– –
-30,000
Closed -$3.22M
ALT icon
90
Altimmune
ALT
$316M
– –
-100,000
Closed -$1.13M
AXSM icon
91
Axsome Therapeutics
AXSM
$6.12B
– –
-30,758
Closed -$2.51M
BMRN icon
92
BioMarin Pharmaceuticals
BMRN
$10.9B
– –
-25,000
Closed -$2.19M
CSTL icon
93
Castle Biosciences
CSTL
$665M
– –
-22,831
Closed -$1.53M
EW icon
94
Edwards Lifesciences
EW
$47.7B
– –
-50,584
Closed -$4.62M
FATE icon
95
Fate Therapeutics
FATE
$111M
– –
-7,615
Closed -$692K
IMVT icon
96
Immunovant
IMVT
$2.88B
– –
-60,781
Closed -$2.81M
MRSN icon
97
Mersana Therapeutics
MRSN
$34.3M
– –
-4,921
Closed -$3.27M
NEPH icon
98
Nephros
NEPH
$42.2M
– –
-167,048
Closed -$1.43M
NVAX icon
99
Novavax
NVAX
$1.24B
– –
-34,498
Closed -$3.85M
QQQ icon
100
Invesco QQQ Trust
QQQ
$365B
– –
0
– –
1 2 3
4
5